• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

患者和一般公众健康状况评估的分析比较:患者和人群健康状况效用的荟萃分析比较。

Health state valuations of patients and the general public analytically compared: a meta-analytical comparison of patient and population health state utilities.

机构信息

Department of Medical Decision Making, Leiden University Medical Centre, Leiden, The Netherlands.

出版信息

Value Health. 2010 Mar-Apr;13(2):306-9. doi: 10.1111/j.1524-4733.2009.00610.x. Epub 2009 Sep 10.

DOI:10.1111/j.1524-4733.2009.00610.x
PMID:19744288
Abstract

OBJECTIVES

To obtain quality-adjusted life-years, different respondent groups, such as patients or the general public, may be asked to value health states. Until now, it remains unclear if the respondent group has an influence on the values obtained. We assessed this issue through meta-analysis.

METHODS

A literature search was performed for studies reporting valuations given by patients and nonpatients. Studies using indirect utility instruments were excluded.

RESULTS

From 30 eligible studies, 40 estimators were retrieved revealing a difference between respondent group (Cohen's d=0.20, P<0.01). When elicitation methods were analyzed separately, patients gave higher valuations than nonpatients using the time trade-off (TTO) (N=25, unstandardized d=0.05, P<0.05) and the visual analog scale (VAS) (N=22, unstandardized d=0.04, P<0.05). When the standard gamble was used, no difference was seen (N=24, unstandardized d=0.01, P=0.70).

CONCLUSION

In contrast with Dolders et al., our results show that patients give higher valuations than members of the general public. For future cost-utility analyses, researchers should be aware of the differential effects of respondent group for the elicitation methods TTO and VAS.

摘要

目的

为了获得质量调整生命年,不同的受访者群体,如患者或普通公众,可能被要求对健康状况进行评估。到目前为止,仍不清楚受访者群体是否会对获得的价值产生影响。我们通过荟萃分析来评估这个问题。

方法

对报告患者和非患者评估值的研究进行了文献检索。排除使用间接效用工具的研究。

结果

从 30 项合格研究中,共检索到 40 个估算值,显示出受访者群体之间的差异(Cohen's d=0.20,P<0.01)。当分别分析 elicitation 方法时,患者使用时间权衡法(TTO)(N=25,未标准化 d=0.05,P<0.05)和视觉模拟量表(VAS)(N=22,未标准化 d=0.04,P<0.05)的评估值高于非患者。当使用标准赌博法时,未观察到差异(N=24,未标准化 d=0.01,P=0.70)。

结论

与 Dolders 等人的研究结果相反,我们的结果表明患者的评估值高于普通公众。对于未来的成本效用分析,研究人员应该意识到受访者群体对 TTO 和 VAS 评估方法的不同影响。

相似文献

1
Health state valuations of patients and the general public analytically compared: a meta-analytical comparison of patient and population health state utilities.患者和一般公众健康状况评估的分析比较:患者和人群健康状况效用的荟萃分析比较。
Value Health. 2010 Mar-Apr;13(2):306-9. doi: 10.1111/j.1524-4733.2009.00610.x. Epub 2009 Sep 10.
2
Individual differences in the use of the response scale determine valuations of hypothetical health states: an empirical study.应答量表使用中的个体差异决定了对假设健康状态的估值:一项实证研究。
BMC Health Serv Res. 2007 Apr 27;7:62. doi: 10.1186/1472-6963-7-62.
3
QALY weights for diabetic retinopathy--a comparison of health state valuations with HUI-3, EQ-5D, EQ-VAS, and TTO.糖尿病视网膜病变的 QALY 权重——HUI-3、EQ-5D、EQ-VAS 和 TTO 健康状态评估的比较。
Value Health. 2012 May;15(3):475-84. doi: 10.1016/j.jval.2011.11.031. Epub 2012 Feb 10.
4
Lead time TTO: leading to better health state valuations?等待时间 TTO:是否会导致更好的健康状态估值?
Health Econ. 2013 Apr;22(4):376-92. doi: 10.1002/hec.2804. Epub 2012 Mar 6.
5
Differences in EQ-5D-3L health state valuations among patients with musculoskeletal diseases, health care professionals and healthy volunteers.骨肌疾病患者、医疗保健专业人员和健康志愿者的 EQ-5D-3L 健康状态估值存在差异。
Eur J Health Econ. 2015 Nov;16(8):865-77. doi: 10.1007/s10198-014-0636-y. Epub 2014 Oct 5.
6
Measuring utilities of severe facial disfigurement and composite tissue allotransplantation of the face in patients with severe face and neck burns from the perspectives of the general public, medical experts and patients.从普通公众、医学专家和患者的角度衡量严重面部毁容和面部复合组织同种异体移植的效用,这些患者患有严重的面颈部烧伤。
Burns. 2015 Nov;41(7):1524-31. doi: 10.1016/j.burns.2015.05.002. Epub 2015 Jun 9.
7
Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.质量调整生命年在儿科护理中缺乏质量:对已发表的儿童健康成本效用研究的批判性综述。
Pediatrics. 2005 May;115(5):e600-14. doi: 10.1542/peds.2004-2127.
8
Valuing the health state 'tinnitus': differences between patients and the general public.评估“耳鸣”健康状态:患者与普通公众之间的差异
Hear Res. 2005 Sep;207(1-2):50-8. doi: 10.1016/j.heares.2005.04.002.
9
The utility score of epilepsy with partial seizure measured by TTO, VAS, and EQ-5D in the general Korean population.一般韩国人群中 TTO、VAS 和 EQ-5D 测量的部分性癫痫效用评分。
Epilepsy Res. 2014 Jul;108(5):963-71. doi: 10.1016/j.eplepsyres.2014.02.014. Epub 2014 Mar 12.
10
Overcoming inherent problems of preference-based techniques for measuring health benefits: an empirical study in the context of kidney transplantation.克服基于偏好的健康效益测量技术的固有问题:肾脏移植背景下的实证研究
BMC Health Serv Res. 2006 Jan 14;6:3. doi: 10.1186/1472-6963-6-3.

引用本文的文献

1
Differences in health state valuation for small, low-risk thyroid cancer between general population and cancer survivors: a cross-sectional analysis.普通人群与癌症幸存者对小型、低风险甲状腺癌健康状态评估的差异:一项横断面分析。
Qual Life Res. 2025 Aug 23. doi: 10.1007/s11136-025-04033-7.
2
Cancer patients' willingness to trade time for health: factors that affect their decision.癌症患者用时间换取健康的意愿:影响其决策的因素。
BMC Public Health. 2025 Jul 3;25(1):2342. doi: 10.1186/s12889-025-23586-3.
3
Does timing matter? The role of health information shocks in measuring willingness to pay.
时机重要吗?健康信息冲击在衡量支付意愿中的作用。
Eur J Health Econ. 2025 Apr 17. doi: 10.1007/s10198-025-01774-7.
4
Health State Utility Values: The Implications of Patient versus Community Ratings in Assessing the Value of Care.健康状态效用值:患者评分与社区评分在评估医疗价值中的意义。
Med Decis Making. 2025 May;45(4):347-357. doi: 10.1177/0272989X251326600. Epub 2025 Mar 22.
5
Do We Understand Unmet Need? A Proposal to Use Length-Of-Life Equivalent (LOLE) as a Patient-Centric Measure of Unmet Need.我们理解未满足的需求吗?一项关于使用寿命等效长度(LOLE)作为以患者为中心的未满足需求衡量指标的提议。
Pharmacoecon Open. 2025 May;9(3):341-350. doi: 10.1007/s41669-025-00560-8. Epub 2025 Feb 17.
6
Valuation of the EORTC Quality of Life Utility Core 10 Dimensions (QLU-C10D) in a Multi-ethnic Asian Setting: How Does Having Cancer Matter?EORTC QLQ-C10D 在多族群亚洲人群中的效用评估:癌症如何影响生存质量?
Pharmacoeconomics. 2024 Dec;42(12):1413-1425. doi: 10.1007/s40273-024-01432-5. Epub 2024 Sep 26.
7
Estimation of Health State Utility Values for Immunoglobulin A Nephropathy: A Time Trade-Off Analysis.免疫球蛋白A肾病健康状态效用值的评估:一项时间权衡分析。
Pharmacoecon Open. 2025 Jan;9(1):83-92. doi: 10.1007/s41669-024-00527-1. Epub 2024 Sep 21.
8
Chinese utility weights for the EORTC cancer-specific utility instrument QLU-C10D.QLU-C10D 量表的 EORTC 癌症特异性效用量表中国效用权重。
Qual Life Res. 2024 Dec;33(12):3335-3349. doi: 10.1007/s11136-024-03776-z. Epub 2024 Sep 13.
9
Comparison of Caregiver and General Population Preferences for Dependency-Related Health States.照顾者与普通人群对与依赖相关健康状态的偏好比较。
Appl Health Econ Health Policy. 2025 Jan;23(1):105-117. doi: 10.1007/s40258-024-00908-x. Epub 2024 Sep 10.
10
Using Patient Preferences in Health Technology Assessment: Evaluating Quality-Adjusted Survival Equivalents (QASE) for the Quantification of Non-health Benefits.利用患者偏好进行卫生技术评估:评估用于量化非健康效益的质量调整生存等价物(QASE)。
Patient. 2024 May;17(3):229-237. doi: 10.1007/s40271-024-00676-9. Epub 2024 Feb 29.